A citation-based method for searching scientific literature

Hetal S Vig, Anne Marie McCarthy, Kaijun Liao, Mirar Bristol Demeter, Tracey Fredericks, Katrina Armstrong. Cancer Epidemiol Biomarkers Prev 2013
Times Cited: 4







List of co-cited articles
13 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Are physician recommendations for BRCA1/2 testing in patients with breast cancer appropriate? A population-based study.
Anne Marie McCarthy, Mirar Bristol, Tracey Fredricks, Lache Wilkins, Irene Roelfsema, Kaijun Liao, Judy A Shea, Peter Groeneveld, Susan M Domchek, Katrina Armstrong. Cancer 2013
16
50

Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.
Nadine Tung, Nancy U Lin, John Kidd, Brian A Allen, Nanda Singh, Richard J Wenstrup, Anne-Renee Hartman, Eric P Winer, Judy E Garber. J Clin Oncol 2016
240
50


BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study.
Hildegunn Høberg-Vetti, Cathrine Bjorvatn, Bent E Fiane, Turid Aas, Kathrine Woie, Helge Espelid, Tone Rusken, Hans Petter Eikesdal, Wenche Listøl, Marianne T Haavind,[...]. Eur J Hum Genet 2016
37
50

Uptake rates for breast cancer genetic testing: a systematic review.
Mary E Ropka, Jennifer Wenzel, Elayne K Phillips, Mir Siadaty, John T Philbrick. Cancer Epidemiol Biomarkers Prev 2006
112
50

Barriers to participating in genetic counseling and BRCA testing during primary treatment for breast cancer.
Kathryn J Schlich-Bakker, Herman F J ten Kroode, Carla C Wárlám-Rodenhuis, Jan van den Bout, Margreet G E M Ausems. Genet Med 2007
52
50

Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk.
Douglas E Levy, Stacey D Byfield, Catherine B Comstock, Judy E Garber, Sapna Syngal, William H Crown, Alexandra E Shields. Genet Med 2011
152
50

Determinants of genetic counseling uptake and its impact on breast cancer outcome: a population-based study.
Aurélie Ayme, Valeria Viassolo, Elisabetta Rapiti, Gérald Fioretta, Hyma Schubert, Christine Bouchardy, Pierre O Chappuis, Simone Benhamou. Breast Cancer Res Treat 2014
14
50

Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities.
Larissa A Meyer, Meaghan E Anderson, Robin A Lacour, Anuj Suri, Molly S Daniels, Diana L Urbauer, Graciela M Nogueras-Gonzalez, Kathleen M Schmeler, David M Gershenson, Karen H Lu. Obstet Gynecol 2010
80
50

Increased uptake of BRCA1/2 genetic testing among African American women with a recent diagnosis of breast cancer.
Lisa R Susswein, Cécile Skrzynia, Leslie A Lange, Jessica K Booker, Mark L Graham, James P Evans. J Clin Oncol 2008
42
50

Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic.
C Winter, M P Nilsson, E Olsson, A M George, Y Chen, A Kvist, T Törngren, J Vallon-Christersson, C Hegardt, J Häkkinen,[...]. Ann Oncol 2016
46
50

Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals.
Terri Febbraro, Katina Robison, Jennifer Scalia Wilbur, Jessica Laprise, Amy Bregar, Vrishali Lopes, Robert Legare, Ashley Stuckey. Gynecol Oncol 2015
60
50

Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer.
D Cragun, D Bonner, J Kim, M R Akbari, S A Narod, A Gomez-Fuego, J D Garcia, S T Vadaparampil, Tuya Pal. Breast Cancer Res Treat 2015
50
50

Breast cancer risk assessment and management in primary care: provider attitudes, practices, and barriers.
Susan A Sabatino, Ellen P McCarthy, Russell S Phillips, Risa B Burns. Cancer Detect Prev 2007
71
25

Clinical genetics provider real-time workflow study.
Elizabeth McPherson, Christina Zaleski, Katrina Benishek, Catherine A McCarty, Philip F Giampietro, Kara Reynolds, Kristen Rasmussen. Genet Med 2008
40
25

Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
Matthew B Yurgelun, Brian Allen, Rajesh R Kaldate, Karla R Bowles, Thaddeus Judkins, Praveen Kaushik, Benjamin B Roa, Richard J Wenstrup, Anne-Renee Hartman, Sapna Syngal. Gastroenterology 2015
142
25

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.
Tom Walsh, Silvia Casadei, Ming K Lee, Christopher C Pennil, Alex S Nord, Anne M Thornton, Wendy Roeb, Kathy J Agnew, Sunday M Stray, Anneka Wickramanayake,[...]. Proc Natl Acad Sci U S A 2011
564
25

Family history-taking in community family practice: implications for genetic screening.
L S Acheson, G L Wiesner, S J Zyzanski, M A Goodwin, K C Stange. Genet Med 2000
174
25

Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.
Joanne Armstrong, Michele Toscano, Nancy Kotchko, Sue Friedman, Marc D Schwartz, Katherine S Virgo, Kristian Lynch, James E Andrews, Claudia X Aguado Loi, Joseph E Bauer,[...]. JAMA Oncol 2015
78
25

Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
488
25

The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services.
D Gareth Evans, Julian Barwell, Diana M Eccles, Amanda Collins, Louise Izatt, Chris Jacobs, Alan Donaldson, Angela F Brady, Andrew Cuthbert, Rachel Harrison,[...]. Breast Cancer Res 2014
178
25

Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians.
Cecelia A Bellcross, Katherine Kolor, Katrina A B Goddard, Ralph J Coates, Michele Reyes, Muin J Khoury. Am J Prev Med 2011
111
25

Diffusion of breast cancer risk assessment in primary care.
Carmen E Guerra, Melani Sherman, Katrina Armstrong. J Am Board Fam Med 2009
32
25

Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.
Mary B Daly, Robert Pilarski, Jennifer E Axilbund, Michael Berry, Saundra S Buys, Beth Crawford, Meagan Farmer, Susan Friedman, Judy E Garber, Seema Khan,[...]. J Natl Compr Canc Netw 2016
111
25

The integration of next-generation sequencing panels in the clinical cancer genetics practice: an institutional experience.
Caitlin B Mauer, Sara M Pirzadeh-Miller, Linda D Robinson, David M Euhus. Genet Med 2014
52
25

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
Robert C Green, Jonathan S Berg, Wayne W Grody, Sarah S Kalia, Bruce R Korf, Christa L Martin, Amy L McGuire, Robert L Nussbaum, Julianne M O'Daniel, Kelly E Ormond,[...]. Genet Med 2013
25

Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers.
Brian Drohan, Constance A Roche, James C Cusack, Kevin S Hughes. Ann Surg Oncol 2012
56
25

The use of a family history risk assessment tool within a community health care system: views of primary care providers.
Carol A Christianson, Karen Potter Powell, Susan Estabrooks Hahn, Susan H Blanton, Jessica Bogacik, Vincent C Henrich. J Genet Couns 2012
21
25

Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer.
Fergus J Couch, Steven N Hart, Priyanka Sharma, Amanda Ewart Toland, Xianshu Wang, Penelope Miron, Janet E Olson, Andrew K Godwin, V Shane Pankratz, Curtis Olswold,[...]. J Clin Oncol 2015
355
25

Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
Nadine Tung, Chiara Battelli, Brian Allen, Rajesh Kaldate, Satish Bhatnagar, Karla Bowles, Kirsten Timms, Judy E Garber, Christina Herold, Leif Ellisen,[...]. Cancer 2015
252
25

Panel Testing Is Not a Panacea.
Jennifer E Axilbund. J Clin Oncol 2016
13
25

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Andrea Desmond, Allison W Kurian, Michele Gabree, Meredith A Mills, Michael J Anderson, Yuya Kobayashi, Nora Horick, Shan Yang, Kristen M Shannon, Nadine Tung,[...]. JAMA Oncol 2015
197
25

Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancer.
Kara N Maxwell, Bradley Wubbenhorst, Kurt D'Andrea, Bradley Garman, Jessica M Long, Jacquelyn Powers, Katherine Rathbun, Jill E Stopfer, Jiajun Zhu, Angela R Bradbury,[...]. Genet Med 2015
92
25

Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award.
Mary-Claire King, Ephrat Levy-Lahad, Amnon Lahad. JAMA 2014
172
25

Genetic testing in young women with breast cancer: results from a Web-based survey.
K J Ruddy, S Gelber, J Shin, J E Garber, R Rosenberg, M Przypysny, A H Partridge. Ann Oncol 2010
17
25

Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.
William J Gradishar, Benjamin O Anderson, Ron Balassanian, Sarah L Blair, Harold J Burstein, Amy Cyr, Anthony D Elias, William B Farrar, Andres Forero, Sharon Hermes Giordano,[...]. J Natl Compr Canc Netw 2016
228
25


The genetic basis for cancer treatment decisions.
Janet E Dancey, Philippe L Bedard, Nicole Onetto, Thomas J Hudson. Cell 2012
190
25

A 26-hour system of highly sensitive whole genome sequencing for emergency management of genetic diseases.
Neil A Miller, Emily G Farrow, Margaret Gibson, Laurel K Willig, Greyson Twist, Byunggil Yoo, Tyler Marrs, Shane Corder, Lisa Krivohlavek, Adam Walter,[...]. Genome Med 2015
117
25

Referral and experience with genetic testing among women with early onset breast cancer.
Karen L Brown, Robin Hutchison, Randi E Zinberg, Margaret M McGovern. Genet Test 2005
27
25

Rescreening for genetic mutations using multi-gene panel testing in patients who previously underwent non-informative genetic screening.
Melissa K Frey, Sarah H Kim, Rebecca Yee Bassett, Jessica Martineau, Emily Dalton, Jing-Yi Chern, Stephanie V Blank. Gynecol Oncol 2015
26
25

A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes.
J M Eggington, K R Bowles, K Moyes, S Manley, L Esterling, S Sizemore, E Rosenthal, A Theisen, J Saam, C Arnell,[...]. Clin Genet 2014
115
25

BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer.
Shoshana M Rosenberg, Kathryn J Ruddy, Rulla M Tamimi, Shari Gelber, Lidia Schapira, Steven Come, Virginia F Borges, Bryce Larsen, Judy E Garber, Ann H Partridge. JAMA Oncol 2016
68
25

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.
Mark E Robson, Angela R Bradbury, Banu Arun, Susan M Domchek, James M Ford, Heather L Hampel, Stephen M Lipkin, Sapna Syngal, Dana S Wollins, Noralane M Lindor. J Clin Oncol 2015
296
25

Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral.
Cecelia A Bellcross, Steven Leadbetter, Sharon Hensley Alford, Lucy A Peipins. Cancer Epidemiol Biomarkers Prev 2013
41
25

Genetic epidemiology of BRCA mutations--family history detects less than 50% of the mutation carriers.
Pål Møller, Anne Irene Hagen, Jaran Apold, Lovise Maehle, Neal Clark, Bent Fiane, Kjell Løvslett, Eivind Hovig, Anita Vabø. Eur J Cancer 2007
82
25

Genetic testing for familial/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany.
Dorothea Gadzicki, D Gareth Evans, Hilary Harris, Claire Julian-Reynier, Irmgard Nippert, Jörg Schmidtke, Aad Tibben, Christi J van Asperen, Brigitte Schlegelberger. J Community Genet 2011
52
25

Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis.
Bernadette A M Heemskerk-Gerritsen, Matti A Rookus, Cora M Aalfs, Margreet G E M Ausems, Johanna M Collée, Liesbeth Jansen, C Marleen Kets, Kristien B M I Keymeulen, Linetta B Koppert, Hanne E J Meijers-Heijboer,[...]. Int J Cancer 2015
82
25

Genetic testing for BRCA1 and BRCA2 in the Province of Ontario.
A Finch, M Wang, A Fine, L Atri, S Khalouei, M Pupavac, B Rosen, A Eisen, C Elser, G Charames,[...]. Clin Genet 2016
14
25

BRCA testing of breast cancer patients: medical specialists' referral patterns, knowledge and attitudes to genetic testing.
E Van Riel, C C Wárlám-Rodenhuis, S Verhoef, E J T H Rutgers, M G E M Ausems. Eur J Cancer Care (Engl) 2010
38
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.